Please review the current opportunities at Y-mAbs.
In the newly established role as Associate Director, GMP QA, Commercial Operations, you will become responsible for GMP compliance of the commercial manufacturing and distribution operations.
Join a company that strives to become the world leader in developing antibody-based cancer products that address clear unmet needs in pediatric and adult oncology
Apply for the position as Associate Medical Director, Clinical Development and join a fast-paced, growing company in the process of expanding its organization to support the continuous growth and the exciting clinical oncology pipeline!
Are you ready to join an expanding and innovative biopharmaceutical company and play a key part in our clinical development efforts?
Come join our dedicated regulatory team at Y-mAbs Therapeutics A/S! Y-mAbs is now looking for a Regulatory Affairs CMC senior manager in a newly established position in Global Regulatory Affairs. You will become an important part of managing regulatory submissions and approvals in new markets and establishing LCM.
Y-mAbs Therapeutics is establishing an in-house focus area of protein engineering within the CMC governance area. The focus area of protein engineering will support our growing pipeline of future product candidates. We are therefore looking for a candidate with both a strong scientific knowledge in the area and with an entrepreneur mindset to lead and grow this focus area.
We are hiring for a Medical Science Liaison position in the US Southeast Region and looking for a good fit candidate to be a part of our highly motivated and skilled Field Medical Affairs Team.
As SADA/TCB pipeline matures and expands we are performing increased numbers of cell-based assays, such as flow cytometry and protein transfections. This new position will provide important support for these assays and improve our capability to express new proteins for continued development.
Exciting toxicology position where you will be responsible for program set-up, oversight, and report for new nonclinical programs.